Accutane Articles
Ranbaxy gains US FDA approval for Absorica
29 May 2012
Teva returns to profit, as 4th quarter 2009 sales leap 33%
16 February 2010
New guidelines to help boost use of 5-ARIs
9 March 2009
EMEA denies "suicide rating for all drugs" claim
18 February 2008
Ranbaxy's FY 2007 profit up 68% $191M
28 January 2008
Ranbaxy's 3rd-qtr net profit soars 48%
5 November 2007
Ranbaxy buys 13 B-MS dermatology drugs
4 June 2007
FDA sets up Accutane warning web site
9 April 2007
Dermatologists report Accutane problems
11 September 2006
Danger to patients from weak US Rx system: CU
12 December 2005
Accutane users to join central registry in USA
22 August 2005
Mylan's full-year EPS hits record
24 May 2004
Second FDA drug imports "blitz" finds 80% come from Canada
9 February 2004
Roche beats forecasts with pharma sales up 13% in first 9 months
27 October 2003
Generics growth boosts Mylan in fiscal 2003
19 May 2003
Ranbaxy cleared to sell isotretinoin in USA
3 February 2003
Ranbaxy gets US OK for generic Accutane
6 January 2003
Ranbaxy gets US OK for generic Ceftin
25 February 2002
Ranbaxy full-year 2001 sales up 22.9%
4 February 2002
Dip in 1st-qtr pharma sales at Roche
11 April 2001
Net income leaps 50% at Roche in 2000, but pharma sales disappoint
28 February 2001
Acquisitions to solve weak Roche pipeline?
15 January 2001
Roche names GSK's Abercrombie to heard N Amer pharma ops
12 January 2001
Roche to restrict ads for acne drug
2 November 2000
US panels seeks restriction on Accutane use
19 September 2000
Roche revenues hit 20 billion Swiss francs
14 October 1999
Roche 1st qtr sales up 4%; Xenical doing well
15 April 1999
Analysts not surprised by Roche results
15 January 1999
Suicide Warning Added To Accutane Label
26 February 1998
US Drugmakers Use Of Internet For Promotion
28 January 1998
Tazarotene - 1st Effective Topical Retinoid For Psoriasis?
18 September 1997
Thalidomide Closer To US Market For Leprosy
10 September 1997
"Two Month Rule" For Acne Sufferers
19 August 1996
US FDA Seeks Patient Data Sheets For All New Scripts
4 September 1995
Disease ManagementThe Way Forward
15 May 1995
ACCUTANE LABELLING CHANGES
27 June 1994
CONFERENCE REPORT: ASCO MEETING
30 May 1994
GENTA TO FILE PLA FOR G-101 IN FRANCE
16 May 1994
RISING SWISS FRANC HITS ROCHE SALES
18 April 1994
ROCHE'S SORIATANE TO REPLACE TEGOSIN?
28 February 1994
ROCHE RECORDS 11% INCREASE IN '93 SALES
17 January 1994
NIZORAL TOPS SKIN DRUG LEAGUE IN 1992
10 January 1994
ISOTRETINOIN EFFECTIVE
25 October 1993
ROCHE PHARMA HEALTHY IN 1st HALF
19 July 1993
CANCER MEDICINES IN DEVELOPMENT
14 June 1993
ARGUS STARTS AR-623 CLINICAL TRIALS
8 February 1993
ACCUTANE AND ROFERON A
2 November 1992
WORLD PRODUCT NEWS IN BRIEF
15 June 1992
ROCHE SEES SALES INCREASE 19% IN 1991
20 January 1992
Showing 1-69 of 69 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
